Calls to Enhance Digital Tracking in the Pharmaceutical Sector to Counter Illicit Drug Networks

Strategic expert Mohamed Ali stated that addressing violations related to illicit drug promotion within the pharmaceutical sector necessitates tackling regulatory gaps and upgrading the medicine distribution framework, emphasizing that individual cases do not represent the profession as a whole. Ali explained that countering organized, transnational networks requires linking health institutions to centralized databases and adopting real-time digital tracking systems to detect the manipulation of medical prescriptions and dispensing logs. He added that combating these crimes demands intelligence and security integration in coordination with health authorities, while stressing the importance of making investigation results public to boost transparency and maintain societal trust in the national healthcare system.